FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to pharmaceutics and concerns a pharmaceutical composition for treatment and prevention of respiratory syncytial virus (RSV) including the respiratory syncytial virus (RSV) fusion protein and a benzodiazepine derivative capable of inhibiting RSV replication.
EFFECT: compositions have improved therapeutic efficiency.
10 cl, 12 ex
Title | Year | Author | Number |
---|---|---|---|
COMBINATION OF HDA INHIBITOR AND ANTIMETABOLITE | 2007 |
|
RU2469717C2 |
COMPOUNDS AND COMPOSITIONS AS PROTEINKINASE INHIBITORS | 2005 |
|
RU2406725C2 |
SPIRO CONDENSED PYRROLIDINE DERIVATIVES AS INHIBITORS OF DEUBIQUITINATING ENZYMES (DUB) | 2017 |
|
RU2730552C2 |
COMBINATION OF HISTONE DEACETYLASE INHIBITORS AND RADIATION | 2006 |
|
RU2436572C2 |
APOPTOSIS-INDUCING AGENTS | 2018 |
|
RU2782469C2 |
ANELLATED CABAMOYLAZAHETEROCYCLES, FOCUSED LIBRARY, PHARMACEUTICAL COMPOSITION AND METHOD FOR ITS PREPARING | 2005 |
|
RU2281947C1 |
COMPOUNDS AND COMPOSITIONS AS CANNABINOID RECEPTOR 1 INHIBITORS | 2005 |
|
RU2431635C2 |
PYRAZOLINE DIONE DERIVATIVES AS NADPH-OXIDASE INHIBITORS | 2010 |
|
RU2569855C2 |
COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF AND METHOD FOR TREATMENT OF CYTOKINE-MEDIATED DISEASE | 2000 |
|
RU2298008C2 |
BIFUNCTION CYTOTOXIC AGENTS CONTAINING PHARMACOPHORE CTI | 2016 |
|
RU2682645C1 |
Authors
Dates
2010-05-10—Published
2005-03-18—Filed